hydralazine has been researched along with Glioblastoma in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Excerpt | Relevance | Reference |
---|---|---|
"A549 (lung cancer) and U373MG (glioblastoma) cells were exposed to radiation with or without six DNMT inhibitors (5-azacytidine, 5-aza-2'-deoxycytidine, zebularine, hydralazine, epigallocatechin gallate, and psammaplin A) for 18 hours prior to radiation, after which cell survival was evaluated via clonogenic assays." | 3.78 | DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. ( Chie, EK; Kim, HJ; Kim, IA; Kim, IH; Kim, JH; Young, PD, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HJ | 1 |
Kim, JH | 1 |
Chie, EK | 1 |
Young, PD | 1 |
Kim, IA | 1 |
Kim, IH | 1 |
Wehner, RJ | 1 |
Romanauskas, VS | 1 |
2 other studies available for hydralazine and Glioblastoma
Article | Year |
---|---|
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Topics: Azacitidine; Caspase 3; Catechin; Cell Line, Tumor; Cytidine; Decitabine; Disulfides; DNA (Cytosine- | 2012 |
An adverse reaction with hydralazine: a case study.
Topics: Blood Pressure; Bradycardia; Brain Neoplasms; Frontal Lobe; Glioblastoma; Humans; Hydralazine; Injec | 1981 |